Brief: AtriCure Q3 Adjusted EPS USD -0.17 Vs. IBES Estimate USD -0.19

AtriCure

29/10/2024 20:01

Oct 29 (Reuters) - AtriCure Q3 operating income USD -7.4 million vs. IBES
estimate USD -8.11 million.
* Q3 gross profit USD 86.8 million
* Q3 gross margin 74.9%
* Q3 revenue USD 115.9 million vs. IBES estimate USD 112.3 million
* Q3 adjusted EBITDA USD 7.9 million vs. IBES estimate USD 6.61 million
* outlook FY adjusted EBITDA USD 26-29 million
* outlook FY adjusted EPS USD -0.8 to -0.74